PHVS (Pharvaris N.V.) Short-Term Debt to Capital
Pharvaris N.V. (PHVS) is implementing AI and automation to accelerate compound synthesis, minimizing manual labor. The business is countering the expansion of industry behemoths developing targeted therapies. This price chart illustrates the trend of the metric, which stands at 0.00. The company is betting on internal development without mergers, while remaining an attractive acquisition target for large corporations during the clinical trial period.
Analytical breakdowns for Pharvaris N.V.
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
- company profitability and valuation multiples indicators:
Fundamental valuation:Pharvaris Corp
A comparative asset analysis allows for an assessment of the stability of Pharvaris N.V. (PHVS), where calculating this metric via the ratio of current liabilities to equity reveals liquidity risks and the probability of cash flow gaps. Monitoring the ratio of short-term debt to equity is critical for maintaining the costly specialized logistics of orphan drugs, ensuring the uninterrupted supply of life-saving therapies to patients.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|ABCL - Short-Term Debt to Equity|tourmalinebio.com (TRML) - Short-Term Debt to Equity Ratio|Precigen (PGEN) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Pharming Group NV|Short-Term Debt to Equity Ratio NKTR|Short-Term Debt to Capital Upstream Pharma|Short-Term Debt to Equity Zenas Biopharma Inc (ZBIO)|immunome.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Current Liabilities to Capital|SEPN - Short-Term Debt to Equity|Current Liabilities to Equity PVLA|SVRA: Short-Term Debt to Capital|rigel.com - Ratio of Short-Term Indebtedness to Capital|ANAB (AnaptysBio) - Short-Term Debt to Capital|Short-Term Debt to Capital Astria Therapeutics Inc|Short-Term Debt to Equity enGene Bio (ENGN)|RAPT (rapt.com) - Ratio of Short-Term Indebtedness to Capital|Aerovate Therapeutics - Short-Term Debt to Equity Ratio|aclaristx.com - Short-Term Debt to Equity|Kyverna Therapeutics, Inc. - Short-Term Debt to Capital|TLSA - Short-Term Debt to Capital|Cabaletta Bio, Inc (CABA) - Short-Term Debt to Equity|Ventyx Biosciences, Inc - Ratio of Short-Term Indebtedness to Capital|THTX (Theratechnologies Inc.) - Short-Term Debt to Capital|avalotx.com (AVTX) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Eledon Pharmaceuticals, Inc. (ELDN)|Short-Term Debt to Capital Coefficient Agenus, Inc.|Climb Bio, Inc. - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital ZURA|ATYR - Short-Term Debt to Equity|ADAG (Adagene) - Short-Term Debt to Capital Ratio|IMA (ikenaoncology.com) - Short-Term Debt to Equity Ratio|STTK - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio EQ|Short-Term Debt to Equity CNTB|Short-Term Debt to Equity Ratio IMUX (Immunic, Inc.)|Short-Term Debt to Capital Coefficient atarabio.com|Short-Term Debt to Equity InflaRx IFRX|XFOR (X4 Pharmaceuticals Inc.) - Current Liabilities to Equity|Adicet - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital CELU (Celularity Inc.)|INMB (INmune Bio, Inc.) - Short-Term Debt to Equity Ratio|BRNS (barinthusbio.com) - Short-Term Debt to Equity|Short-Term Debt to Equity Kezar Life Sciences, Inc.|SAB Biotherapeutics Inc. (SABS) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Akari Therapeutics plc (AKTX)|ENLV: Current Liabilities to Equity|Short-Term Debt to Capital QTTB (Q32 Bio)|Ratio of Short-Term Indebtedness to Capital GOVX|Edesa Biotech - Short-Term Debt to Capital|IBIO - Short-Term Debt to Capital|carismatx.com (CARM) - Short-Term Debt to Equity|XTL Bio - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Bolt Biotherapeutics Inc.|Short-Term Debt to Equity Ratio HCW Biologics Inc (HCWB)|Short-Term Debt to Capital APVO|Short-Term Debt to Capital aimimmuno.com (AIM)|Aditxt, Inc. - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital GRI|XORTX Therapeutics Inc. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient reshapelifesciences.com HIND|Revelation Biosciences, Inc. (REVB) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Indaptus Therapeutics Inc|Short-Term Debt to Equity Scinai|Short-Term Debt to Equity Ratio CalciMedica Corp (CALI)|Short-Term Debt to Equity Ratio AFMD (Affimed)|Short-Term Debt to Capital allakos.com (ALLK)|Short-Term Debt to Equity HOOKIPA Pharma HOOK|IGMS: Short-Term Debt to Capital Ratio|iTeos - Short-Term Debt to Capital|Current Liabilities to Capital Ocean Biomedical Corp|TC Biopharm (TCBP) - Short-Term Debt to Equity|Current Liabilities to Equity THRD (thirdharmonicbio.com)